Hodge A - Search Results

1

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.

Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. Among authors: hodge a. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.

2

Global multi-stakeholder endorsement of the MAFLD definition.

Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.

3

Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial.

Saadati S, Cameron J, Menon K, Hodge A, Lu ZX, de Courten M, Feehan J, de Courten B. Saadati S, et al. Among authors: hodge a. Nutrients. 2023 Nov 19;15(22):4835. doi: 10.3390/nu15224835. Nutrients. 2023. PMID: 38004228 Free PMC article. Clinical Trial.

4

Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis.

Francque SM, Hodge A, Boursier J, Younes ZH, Rodriguez-Araujo G, Park GS, Alkhouri N, Abdelmalek MF. Francque SM, et al. Among authors: hodge a. Hepatol Commun. 2024 Jan 29;8(2):e0335. doi: 10.1097/HC9.0000000000000335. eCollection 2024 Feb 1. Hepatol Commun. 2024. PMID: 38285756 Free PMC article. Clinical Trial.

5

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Hui JM, et al. Among authors: hodge a. Hepatology. 2004 Jul;40(1):46-54. doi: 10.1002/hep.20280. Hepatology. 2004. PMID: 15239085

6

Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis.

Kuk N, Hodge A, Sun Y, Correia J, Alhomrani M, Samuel C, Moore G, Lim R, Sievert W. Kuk N, et al. Among authors: hodge a. J Gastroenterol Hepatol. 2019 Aug;34(8):1441-1449. doi: 10.1111/jgh.14643. Epub 2019 Apr 2. J Gastroenterol Hepatol. 2019. PMID: 30821873

7

Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives.

Clayton-Chubb D, Kemp W, Majeed A, Lubel JS, Hodge A, Roberts SK. Clayton-Chubb D, et al. Among authors: hodge a. Nutrients. 2023 Jan 29;15(3):687. doi: 10.3390/nu15030687. Nutrients. 2023. PMID: 36771394 Free PMC article. Review.

8

Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.

Manuelpillai U, Lourensz D, Vaghjiani V, Tchongue J, Lacey D, Tee JY, Murthi P, Chan J, Hodge A, Sievert W. Manuelpillai U, et al. Among authors: hodge a. PLoS One. 2012;7(6):e38631. doi: 10.1371/journal.pone.0038631. Epub 2012 Jun 14. PLoS One. 2012. PMID: 22719909 Free PMC article.

9

Reply to Abenavoli et al. Comment on "Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687".

Clayton-Chubb D, Kemp W, Majeed A, Lubel JS, Hodge A, Roberts SK. Clayton-Chubb D, et al. Among authors: hodge a. Nutrients. 2023 Jun 27;15(13):2908. doi: 10.3390/nu15132908. Nutrients. 2023. PMID: 37447237 Free PMC article.

10

Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B.

Hodge A, Lim S, Goh E, Wong O, Marsh P, Knight V, Sievert W, de Courten B. Hodge A, et al. Nutrients. 2017 Jan 10;9(1):56. doi: 10.3390/nu9010056. Nutrients. 2017. PMID: 28075394 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

613 results

Search Page